Ischemic Cerebrovascular Disease Clinical Trial
Official title:
The Optimal Regimen of Medical Treatment in Endovascular Therapy in Ischemic Cerebrovascular Disease Based on Clopidogrel Resistance
1. Clopidogrel resistance is common in patients of ischemic cerebrovascular disease.
2. Genetic polymorphisms are the most important factors to clopidogrel resistance.
3. The purpose of this study is to find the genes which are the related to clopidogrel
resistance.
4. Through gene sequencing, we can filter patient of clopidogrel resistance, so another
drug maybe used to avoid the undesired efficacy.
n/a
Observational Model: Cohort, Time Perspective: Retrospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03589053 -
Limb Remote Ischemic Conditioning and Cerebrovascular Reserve
|
Phase 2 | |
| Not yet recruiting |
NCT03153878 -
The Prospective Cohort Study on the Benefit-risk of Antithrombotic or Anticoagulant Therapy in Patients With Unruptured Intracranial Aneurysms Associated With Ischemic Heart Disease or Ischemic Cerebrovascular Disease
|
N/A | |
| Completed |
NCT02966418 -
Hypoxic Preconditioning on Patients
|
N/A | |
| Recruiting |
NCT05232240 -
Blood Pressure Variability in Non-hypertensive Patients With Ischemic Cerebrovascular Disease
|
||
| Not yet recruiting |
NCT06001073 -
Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics
|
||
| Recruiting |
NCT03794843 -
Bioavailability Comparison Study of Two Types of Nimodipine Injections in Healthy Volunteers
|
Early Phase 1 | |
| Not yet recruiting |
NCT05716646 -
In the Real World Study, the Efficacy and Adverse Reactions of Ticagrelor on Ischemic Cerebrovascular Disease
|
||
| Recruiting |
NCT03256513 -
The Safety and Efficacy of Peri-procedure Blood Pressure Management of Revascularization
|
N/A |